Ovalbumin peptide–Major histocompatibility complex complex (OVA peptide/MHC complex)

The OVA peptide/MHC complex is a recombinant or model antigenic entity in which a peptide fragment derived from ovalbumin is presented by a major histocompatibility complex molecule. The **ovalbumin (OVA) peptide**, commonly residues 257–264 (SIINFEKL) for class I H-2Kb or 323–339 for class II I-A(d), is loaded into the peptide-binding groove of the respective MHC molecule. This complex is a prototypical tool for probing specific immune responses, especially the mechanisms by which T cell receptors (TCRs) recognize peptide–MHC complexes and initiate adaptive immunity. It is extensively used in immunology to study antigen presentation, T cell activation, epitope specificity, and the molecular details of TCR–pMHC interactions[1][2][3][4][5][6][7][8]. The OVA peptide/MHC complex is not a drug target in itself but a research tool crucial for mechanistic insights into how adaptive immune cells recognize antigens and initiate immune responses. The structure is well-characterized, including via crystallographic analysis (2.5 Å; SIINFEKL–H-2Kb)[1][2], and used to explore immune recognition, peptide–MHC binding features, and the determinants of T cell specificity. This system is foundational for developing diagnostics, vaccines, and immunotherapies but is not directly modulated by therapeutic agents.

Other names

OVA–MHC complexOVA–H-2Kb complexOvalbumin peptide/MHC complexOvalbumin (257–264)–H-2Kb (for class I)Ovalbumin (323–339)–I-A(d) (for class II)

null (no drugs act directly on this complex; it functions by binding T cell receptors and activating T cells)